Literature DB >> 4902712

[Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. I. Body weight, carbohydrate metabolism and immunoreactive insulin].

A Appels, R Kattermann, H Proschek, K Hubrich, H Frerichs, H D Söling, W Creutzfeldt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4902712     DOI： 10.1007/bf00430097

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  46 in total

1.  PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICS.

Authors:  D P PATEL; J M STOWERS
Journal:  Lancet       Date:  1964-08-08       Impact factor: 79.321

2.  PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICS.

Authors:  C WELLER
Journal:  Lancet       Date:  1965-01-02       Impact factor: 79.321

3.  THE EFFECT OF METFORMIN ON WEIGHT LOSS IN OBESITY.

Authors:  J PEDERSEN
Journal:  Acta Endocrinol (Copenh)       Date:  1965-07

4.  Clinical trials with phenethyldiguanide in selected patients.

Authors:  R E TRANQUADA; C R KLEEMAN; J BROWN
Journal:  Am J Med Sci       Date:  1959-08       Impact factor: 2.378

5.  Phenformin in diabetic treatment. Preliminary results with long-acting capsules.

Authors:  J M MOSS; D E DELAWTER; S A TYROLER; J B FIELD
Journal:  Med Times       Date:  1961-06

6.  Pharmacology and mode of action of the sulphonylureas in man.

Authors:  J M STOWERS; R F MAHLER; R B HUNTER
Journal:  Lancet       Date:  1958-02-08       Impact factor: 79.321

7.  Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects.

Authors:  I P ACKERMAN; J W CONN; S S FAJANS; R D GITTLER; A R HENNES; R D JOHNSON; L H LOUIS; H S SELTZER; B L WAJCHENBERG
Journal:  Metabolism       Date:  1956-11       Impact factor: 8.694

8.  Effect of chlorpropamide on serum glucose and immunoreactive insulin concentrations in patients with maturity-onset diabetes mellitus.

Authors:  G Reaven; J Dray
Journal:  Diabetes       Date:  1967-07       Impact factor: 9.461

9.  Clinical and pharmacological effects of substance BZ-55 in diabetes; (p-aminophenylsulfonyl butylcarbamide).

Authors:  R C ANDERSON; W R KIRTLEY; A S RIDOLFO; M A ROOT
Journal:  Diabetes       Date:  1956 Sep-Oct       Impact factor: 9.461

10.  Influence of phenethylbiguanide on lactic, pyruvic and citric acids in diabetic patients.

Authors:  J W CRAIG; M MILLER; H WOODWARD; E MERIK
Journal:  Diabetes       Date:  1960 May-Jun       Impact factor: 9.461
View more
  5 in total

1.  [Mechanism of action of biguanides, with special reference to phenethylbiguanide, in the human being].

Authors:  B L Wajchenberg; A Halpern; J Shnaider
Journal:  Acta Diabetol Lat       Date:  1972 Mar-Apr

2.  [Investigations of the effects of diet, tolbutamide and buformin and their combination on body weight and several metabolic parameters in diabetics. II. Free fatty acids, ketone bodies, triglycerides and cholesterol in blood].

Authors:  R Kattermann; A Appels; K Hubrich; H Proschek; H D Söling; W Creutzfeldt
Journal:  Diabetologia       Date:  1968-08       Impact factor: 10.122

3.  Inhibition of intestinal amino acid transport by blood sugar lowering biguanides.

Authors:  W F Caspary; W Creutzfeldt
Journal:  Diabetologia       Date:  1973-02       Impact factor: 10.122

4.  Glucose tolerance, plasma insulin and lipids in diabetic subjects before and after treatment with a new sulfonylurea compounds, Ro 6-4563.

Authors:  P Berchtold; P Björntorp; A Gustafson; A Jonsson; S E Fagerberg
Journal:  Eur J Clin Pharmacol       Date:  1971-12       Impact factor: 2.953

Review 5.  [Weight reduction by diet, drugs and operative methods in obesity].

Authors:  H Liebermeister
Journal:  Klin Wochenschr       Date:  1971-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.